141 related articles for article (PubMed ID: 33616477)
21. Analysis of T cell receptor variable regions and complementarity determining region 3 of infiltrating T lymphocytes in the liver of patients with chronic type B hepatitis.
Maru Y; Yokosuka O; Imazeki F; Saisho H; Omata M
Intervirology; 2003; 46(5):277-88. PubMed ID: 14555848
[TBL] [Abstract][Full Text] [Related]
22. B-cell Receptor Recombinations in Lung Adenocarcinoma Exome Files Correlate With a Higher Overall Survival Rate.
Tu YN; Tong WL; Callahan BM; Chobrutskiy BI; Blanck G
Anticancer Res; 2020 Apr; 40(4):2043-2051. PubMed ID: 32234895
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the CDR3 length repertoire and the diversity of TCR alpha chain in human peripheral blood T lymphocytes.
Yao XS; Diao Y; Sun WB; Luo JM; Qin M; Tang XY
Cell Mol Immunol; 2007 Jun; 4(3):215-20. PubMed ID: 17601376
[TBL] [Abstract][Full Text] [Related]
24. Blood-based T cell receptor anti-viral CDR3s are associated with worse overall survival for neuroblastoma.
Kacsoh DB; Diaz MJ; Gozlan EC; Sahoo A; Song JJ; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Cancer Res Clin Oncol; 2023 Oct; 149(13):12047-12056. PubMed ID: 37421457
[TBL] [Abstract][Full Text] [Related]
25. TRB CDR3 chemical complementarity with HBV epitopes correlates with increased hepatocellular carcinoma, disease-free survival.
Song JJ; Chobrutskiy A; Chobrutskiy BI; Cios KJ; Huda TI; Eakins RA; Diaz MJ; Blanck G
J Med Virol; 2023 Aug; 95(8):e29043. PubMed ID: 37621059
[TBL] [Abstract][Full Text] [Related]
26. Chemical complementarity between immune receptor CDR3s and candidate cancer antigens correlating with reduced survival: evidence for outcome mitigation with corticosteroid treatments.
Patel AR; Patel DN; Tu YN; Yeagley M; Chobrutskiy A; Chobrutskiy BI; Blanck G
J Biomol Struct Dyn; 2023 Jul; 41(10):4632-4640. PubMed ID: 35538689
[TBL] [Abstract][Full Text] [Related]
27. T cell receptor CDR3 loop length repertoire is determined primarily by features of the V(D)J recombination reaction.
Hughes MM; Yassai M; Sedy JR; Wehrly TD; Huang CY; Kanagawa O; Gorski J; Sleckman BP
Eur J Immunol; 2003 Jun; 33(6):1568-75. PubMed ID: 12778474
[TBL] [Abstract][Full Text] [Related]
28. Specific TCR V-J gene segment recombinations leading to the identification pan-V-J CDR3s associated with survival distinctions: diffuse large B-cell lymphoma.
Cios KJ; Huda TI; Eakins RA; Mihyu MM; Blanck G
Leuk Lymphoma; 2022 Jun; 63(6):1314-1322. PubMed ID: 35019822
[TBL] [Abstract][Full Text] [Related]
29. Immune receptor recombinations from breast cancer exome files, independently and in combination with specific HLA alleles, correlate with better survival rates.
Tong WL; Callahan BM; Tu YN; Zaman S; Chobrutskiy BI; Blanck G
Breast Cancer Res Treat; 2019 Jan; 173(1):167-177. PubMed ID: 30229447
[TBL] [Abstract][Full Text] [Related]
30. TRB-J1 usage, in combination with the HLA-A*01:01 allele, represents an apparent survival advantage for uterine corpus endometrial carcinoma: Comparisons with microscopic assessments of lymphocyte infiltrates.
Clark KR; Tong WL; Callahan BM; Yavorski JM; Tu YN; Blanck G
Int J Immunogenet; 2019 Feb; 46(1):31-37. PubMed ID: 30474304
[TBL] [Abstract][Full Text] [Related]
31. Composition and variation analysis of the TCR β-chain CDR3 repertoire in systemic lupus erythematosus using high-throughput sequencing.
Sui W; Hou X; Zou G; Che W; Yang M; Zheng C; Liu F; Chen P; Wei X; Lai L; Dai Y
Mol Immunol; 2015 Oct; 67(2 Pt B):455-64. PubMed ID: 26227771
[TBL] [Abstract][Full Text] [Related]
32. Repertoires of T cell receptors expressed by graft-infiltrating T cells evolve during long-term recall responses to single minor histocompatibility antigens.
Wettstein PJ; Strausbauch M; Borson N
Int Immunol; 2007 Apr; 19(4):523-34. PubMed ID: 17369191
[TBL] [Abstract][Full Text] [Related]
33. Characterization of conserved CDR3 sequence of TCR alpha- and beta-chain genes in peripheral blood T-cells from patients with diffuse large B-cell lymphoma.
Yin Q; Tan H; Chen S; Yang L; Ye J; Li Y
Hematology; 2010 Feb; 15(1):48-57. PubMed ID: 20132663
[TBL] [Abstract][Full Text] [Related]
34. A Bioinformatics Assessment Indicating Better Outcomes With Breast Cancer Resident, Immunoglobulin CDR3-MMP2 Binding.
Mandala SR; Thomson AJ; Gozlan EC; Patel DN; Chobrutskiy A; Chobrutskiy BI; Blanck G
Cancer Genomics Proteomics; 2023; 20(3):239-246. PubMed ID: 37093687
[TBL] [Abstract][Full Text] [Related]
35. Chemical Complementarity of Breast Cancer Resident, T-Cell Receptor CDR3 Domains and the Cancer Antigen, ARMC3, is Associated With Higher Levels of Survival and Granzyme Expression.
Pakasticali N; Chobrutskiy A; Patel DN; Hsiang M; Zaman S; Cios KJ; Blanck G; Chobrutskiy BI
Cancer Inform; 2023; 22():11769351231177269. PubMed ID: 37313373
[TBL] [Abstract][Full Text] [Related]
36. A comparison of immune receptor recombination databases sourced from tumour exome or RNAseq files: Verifications of immunological distinctions between primary and metastatic melanoma.
Patel DN; Yeagley M; Arturo JF; Falasiri S; Chobrutskiy BI; Gozlan EC; Blanck G
Int J Immunogenet; 2021 Oct; 48(5):409-418. PubMed ID: 34298587
[TBL] [Abstract][Full Text] [Related]
37. Assessing microenvironment immunogenicity using tumor specimen exomes: Co-detection of TcR-α/β V(D)J recombinations correlates with PD-1 expression.
Tu YN; Tong WL; Samy MD; Yavorski JM; Kim M; Blanck G
Int J Cancer; 2017 Jun; 140(11):2568-2576. PubMed ID: 28256716
[TBL] [Abstract][Full Text] [Related]
38. Analysis of CDR3 Sequences from T-Cell Receptor β in Acute Respiratory Distress Syndrome.
Hey S; Whyte D; Hoang MC; Le N; Natvig J; Wingfield C; Onyeama C; Howrylak J; Toby IT
Biomolecules; 2023 May; 13(5):. PubMed ID: 37238695
[TBL] [Abstract][Full Text] [Related]
39. T cell receptor gene recombinations in human tumor specimen exome files: detection of T cell receptor-β VDJ recombinations associates with a favorable oncologic outcome for bladder cancer.
Samy MD; Tong WL; Yavorski JM; Sexton WJ; Blanck G
Cancer Immunol Immunother; 2017 Mar; 66(3):403-410. PubMed ID: 27995306
[TBL] [Abstract][Full Text] [Related]
40. Fine specificity of TCR complementarity-determining region residues and lipid antigen hydrophilic moieties in the recognition of a CD1-lipid complex.
Grant EP; Beckman EM; Behar SM; Degano M; Frederique D; Besra GS; Wilson IA; Porcelli SA; Furlong ST; Brenner MB
J Immunol; 2002 Apr; 168(8):3933-40. PubMed ID: 11937549
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
